GO
Loading...

Enter multiple symbols separated by commas

Gilead Sciences Inc

More

  • NEW YORK, April 24- Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector. Companies reporting first-quarter earnings next week include Bristol-Meyers Squibb Co,...

  • April 24- European health regulators warned on Friday against using Gilead Sciences Inc's and Bristol-Myers Squibb Co's hepatitis C medicines along with amiodarone, a drug used to regulate the heartbeat of people with heart rhythm disorders. The European Medicines Agency said there is a risk of severe bradycardia, or heart block, when Gilead's drug Harvoni...

  • Growth? 25 cheap stocks with booming earnings Thursday, 16 Apr 2015 | 6:00 AM ET
    Traders work the floor of the New York Stock Exchange.

    A bleak outlook for earnings threatens to rain on the S&P's march towards new highs this year. Here's what to buy.

  • Demand for newer cancer and multiple sclerosis treatments, price increases on branded medicines, particularly insulin products for diabetes, and the entry of few new generic versions of big-selling drugs also contributed to the double-digit spending rise in 2014, the report by IMS Health Holdings Inc found. "We certainly expect to see growth in the market...

  • 8 best stocks to outfox the market Thursday, 9 Apr 2015 | 10:05 AM ET
    Traders on the floor of the New York Stock Exchange.

    Finding cheap stocks isn't easy anymore. You'll need to be a bit more sly to outfox the market, reports USA Today.

  • Charts say market headed lower. What to sell Monday, 6 Apr 2015 | 11:02 AM ET
    NYSE New York Stock Exchange traders markets

    Technical analysts, those who study charts to make buying and selling decisions, believe a bigger pullback could begin this week.

  • Early movers: HLF, TSLA, QCOM, IBM, TM & more Monday, 6 Apr 2015 | 8:47 AM ET
    Trader on the floor of the NYSE

    Some of the names on the move ahead of the open.

  • Earnings outlook grows bleak. What to buy Wednesday, 1 Apr 2015 | 12:16 PM ET
    A file photo of a FedEx truck

    The upcoming earnings season is forging a bleak outlook for investors. CNBC Pro highlights some of the top picks on the street.

  • Cramer: The best places for you to put new money Monday, 30 Mar 2015 | 6:55 PM ET
    A Cofor worker wearing a safety hard hat moves drilling pipes near to a rig at the geothermal energy drilling site operated by Semhach SA in Villejuif, France.

    Jim Cramer reveals the top places to invest new money on the stock market.

  • March 26- French drugmaker Genfit SA said on Thursday it will begin a late stage trial later this year of its lead treatment for a liver-destroying condition, saying it failed a midstage trial in part due to its inclusion of many patients with a mild form of the disease. When adjusting for those factors, the results were "quite robust for NASH," Dean Hum, the company's...

  • Biotech woes: Deja vu all over again Thursday, 26 Mar 2015 | 12:59 PM ET
    Biotech

    For biotech watchers, it's deja vu all over again. Through Wednesday, the Nasdaq Biotechnology Index dropped 6.9 percent since the close March 20.

  • March 26- Conatus Pharmaceuticals Inc said its experimental lead drug was more effective than a placebo in a mid-stage study in patients with a form of fatty liver disease. Several drugmakers, including Gilead Sciences Inc, Intercept Pharmaceuticals Inc and France's Genfit SA, are in the race to develop treatments. Conatus estimates that about 2 million...

  • Conatus Pharma's liver drug succeeds in mid-stage study Thursday, 26 Mar 2015 | 7:02 AM ET

    March 26- Conatus Pharmaceuticals Inc said its experimental lead drug was more effective than a placebo in a mid-stage study in patients with a form of fatty liver disease. Several drugmakers, including Gilead Sciences Inc, Intercept Pharmaceuticals Inc and France's Genfit SA, are in the race to develop treatments. Conatus estimates that about 2 million...

  • BOSTON, March 25- CEOs at large U.S. companies collectively realized at least $6 billion more in compensation than initially estimated in annual disclosures in the five years after the financial crisis first hit, according to a Reuters analysis. About 300 CEOs who served throughout the 2009-2013 period at S&P 500 companies together realized about $22 billion...

  • Biotech done? And an under-the-radar top stock Tuesday, 24 Mar 2015 | 12:27 PM ET
    Harvoni

    In his latest "New Ideas" column for CNBC Pro, Brian Sullivan discusses the dollar-oil link, a biotech bubble and the hottest stock of the year.

  • *Dollar dips but oversupply worry weighs on oil. NEW YORK, March 23- U.S. stocks were little changed on Monday on the heels of a rally in the prior week, as investors weighed fluctuations in the dollar and its impact on other markets, including crude prices. The Nasdaq was less than 0.5 percent of a closing record set on March 10, 2000.

  • US STOCKS-Wall St little changed as energy pares gains Monday, 23 Mar 2015 | 12:29 PM ET

    *Dollar weakens, supporting crude prices. NEW YORK, March 23- U.S. stocks were little changed on Monday, following strong gains in major indexes the previous week, as investors assessed gyrations in the dollar and crude prices and their impact on equities. "The market has been in a back-and-forth motion for the last couple of weeks, caught between the potential for...

  • US STOCKS-Stocks up as dollar ads to losses, oil gains Monday, 23 Mar 2015 | 10:06 AM ET

    *U.S. dollar extends losses, crude turns positive. NEW YORK, March 23- U.S. stocks edged higher on Monday following strong gains in major indexes the previous week, as investors assessed gyrations in the dollar and crude prices and their impact on equities. "The market has been in a back-and-forth motion for the last couple of weeks, caught between the potential for...

  • *Brent, WTI prices fall again after Saudi comment on supply. NEW YORK, March 23- U.S. stocks were set to dip at the open on Monday following strong gains in major indexes the previous week, as investors assessed gyrations in the dollar and crude prices and their impact on equities. "The market has been in a back and forth motion for the last couple of weeks, caught between...

  • NEW YORK, March 23- U.S. stock index futures ticked lower on Monday following strong gains in major indexes last week, as investors eyed negotiations over the future of Greece in the euro zone and as oil prices fell further. *German Chancellor Angela Merkel and Greek Prime Minister Alexis Tsipras were set to meet in Berlin, and Tsipras' list of reform proposals will...